Consumption of bioactive molecules protecting from necrotising enterocolitis in premature newborns receiving natural or pasteurised human milk. Abstract

Autor: C. Palix, C. Garcia, P. Deprez, V. Millet, S. Confort Gouny, M. Bernard, M. Armand, N. W. Lutz, Catherine Gire, R. D. Duan
Přispěvatelé: Nutriments Lipidiques et Prévention des Maladies Métaboliques, Université de la Méditerranée - Aix-Marseille 2-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Lund University [Lund], Centre National de la Recherche Scientifique (CNRS), Faculté de Médecine de la Timone, Département de néonatalogie, CHU Marseille, ProdInra, Migration
Jazyk: angličtina
Rok vydání: 2007
Předmět:
Zdroj: Joint meeting of the Société Française de Nutrition and The Nutrition Society
Joint meeting of the Société Française de Nutrition and The Nutrition Society, Dec 2007, Lille, France. ⟨10.1017/S0029665108008409⟩
Proceedings of the Nutrition Society
Proceedings of the Nutrition Society, Cambridge University Press (CUP), 2008, 67, pp.E208. ⟨10.1017/S0029665108008409⟩
Proceedings of the Nutrition Society, 2008, 67, pp.E208. ⟨10.1017/S0029665108008409⟩
ISSN: 0029-6651
1475-2719
DOI: 10.1017/S0029665108008409⟩
Popis: The aim of the present study was to investigate, in very-low-birth-weight (VLBW) premature newborns susceptible to developing anecrotising enterocolitis (NEC), the consumption of bioactive molecules (DHA, sphingomyelin (SM), acid sphingomyelinase (Smase), andCD14) over 1 month, and to compare their levels in natural motherOs milk (NM) v. pasteurised motherOs milk from a milk bank (PM).Nine VLBW premature newborn babies (< 1 kg body weight, < 32 weeks of gestational age) were followed up for 4 weeks after thecommencement of digestive stimulation using NM or PM
Databáze: OpenAIRE